Trump Administration

Dear Research Advocate: Americans spent $8.4 billion on Halloween in 2016 -- and no doubt will spend even more this year-- enough to fund the Agency for Healthcare Research and Quality (AHRQ) for 17+ years! What we spend to improve the quality of health care delivery represents only about 0.012% of the $3.3 trillion we spend on health care. Stats like these help place research -- in this case health services research (HSR) -- spending into perspective. (For more advocacy-relevant info, see our fact sheet .) The vision for AHRQ that Director Gopal Khanna shares in this terrific blog post underscores why a far greater investment in HSR makes strategic sense for our nation. More on what money...
Dear Research Advocate: The Trump Administration released its first list of science priorities , an annual White House document intended to guide federal agency budget-making as it relates to research and development. You are likely getting tired of me asserting that the news is mixed when it comes to the goings on in Washington...the news here is mixed. There are several glaring and disturbing, albeit unsurprising, omissions: e.g., no acknowledgement that our nation is grossly and dangerously underfunding R&D relative to the threats we face and the returns it generates; no reference to leveraging R&D against climate change. But there are aspects of this document that are heartening...
Dear Research Advocate, I am pleased to announce that Senator Lamar Alexander (R-TN) will receive the Edwin C. Whitehead Award at our Advocacy Awards Dinner on March 15 in Washington, D.C., for his steadfast commitment to improving the lives of Americans through research, and for leading passage of the 21st Century Cures Act in the Senate. Join us in honoring him! This week, Research!America issued a statement and signed on to a letter spearheaded by AAAS calling on President Trump to rescind his executive order (EO) establishing a temporary ban on certain immigrants. Another Presidential EO placed a temporary hiring freeze on all federal employees, with limited exceptions. A memo from OMB...
Dear Research Advocate, With so much going on in -- and about -- Washington, D.C., it’s easy to overlook the matter of still-unresolved FY17 appropriations. There are members of Congress on both sides of the aisle and in both chambers calling for completion of those bills, and we agree. That’s what our elected representatives should be doing instead of kicking the can down the road with yet another extension of the continuing resolution (CR). Yes, it’s true that if Congress takes up work to complete FY17 spending bills, members will be tasked with developing FY17 and FY18 bills at the same time. Some think this will be difficult for the Senate, with its schedule packed with confirmation...
Dear Research Advocate, Happy New Year! As I contemplate my list of New Year’s resolutions, I know there will be additions even after January 1st. I look forward to the wealth of opportunity for positive change in 2017. My first resolution is to engage -- and encourage and assist other stakeholders to engage -- with our elected representatives in 2017. The new year and the new President and Congress will bring changes we can count on, but outcomes that are unclear. For instance, the President-elect has placed significant emphasis on strengthening our nation’s infrastructure. One clear weakness in that infrastructure shows itself when infectious disease outbreaks threaten the public health...
Dear Research Advocate, Research advocates played a critically important role in shaping and ultimately assuring passage of the 21st Century Cures (21st CC) legislation this week. It was a long road: advocacy is labor intensive, but it works. Read our full statement released after the Senate vote. Here is information on the bill and on the vote counts in the House and Senate . I hope you’ll use this editable email to thank your Senators and Representatives for voting yes (an overwhelming majority in both chambers of Congress did!). The end of the 114th Congress is nigh; we expect that tomorrow the Senate will pass the House-approved Continuing Resolution (CR) to flat fund most government...

Sidebar Quote

Without continued support for health research, many of the most promising young scientists, their ideas and a myriad of potentially life-changing scientific breakthroughs will vanish into oblivion.
Paul Marinec, PhD; University of California San Francisco